Angola vs Côte d'Ivoire: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Angola
- Côte d'Ivoire
How they compare
Côte d'Ivoire currently reports 22,691 deaths against 14,494 deaths in Angola, a difference of 8,197 deaths.
That makes Côte d'Ivoire's figure about 1.6 times Angola's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Côte d'Ivoire ahead.
Angola ranks 16th and Côte d'Ivoire ranks 14th of 157 countries.
Côte d'Ivoire has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Angola | Côte d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 765.87 deaths | 5,020 deaths | 4,254 deaths | Côte d'Ivoire |
| 2010s | 7,024 deaths | 19,082 deaths | 12,057 deaths | Côte d'Ivoire |
| 2020s | 12,363 deaths | 22,683 deaths | 10,320 deaths | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Angola or Côte d'Ivoire?
- Côte d'Ivoire, at 22,691 deaths against 14,494 deaths in Angola as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Angola and Côte d'Ivoire?
- 8,197 deaths, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Angola and Côte d'Ivoire?
- 35 years are reported by both, from 1990 to 2024.
- How do Angola and Côte d'Ivoire rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Angola ranks 16th and Côte d'Ivoire ranks 14th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.